| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myelodysplastic Syndromes | 60 | 2024 | 1393 | 9.810 |
Why?
|
| Hematopoiesis | 56 | 2023 | 2046 | 7.000 |
Why?
|
| Hematologic Neoplasms | 28 | 2023 | 1895 | 4.550 |
Why?
|
| Leukemia, Myeloid, Acute | 48 | 2024 | 3609 | 4.470 |
Why?
|
| Thalidomide | 17 | 2024 | 885 | 4.400 |
Why?
|
| Dioxygenases | 21 | 2024 | 346 | 4.010 |
Why?
|
| Hematopoietic Stem Cells | 46 | 2024 | 3388 | 3.800 |
Why?
|
| Mutation | 99 | 2024 | 30002 | 3.530 |
Why?
|
| Myeloproliferative Disorders | 17 | 2024 | 609 | 2.710 |
Why?
|
| Janus Kinase 2 | 18 | 2024 | 559 | 2.700 |
Why?
|
| Chromosomes, Human, Pair 5 | 18 | 2022 | 386 | 2.460 |
Why?
|
| Ubiquitin-Protein Ligases | 17 | 2024 | 1892 | 2.460 |
Why?
|
| Tumor Suppressor Protein p53 | 30 | 2024 | 2915 | 2.280 |
Why?
|
| Ribosomal Proteins | 15 | 2019 | 370 | 2.240 |
Why?
|
| Chromosome Deletion | 19 | 2022 | 1386 | 1.970 |
Why?
|
| Erythropoiesis | 15 | 2020 | 683 | 1.950 |
Why?
|
| Precancerous Conditions | 7 | 2023 | 982 | 1.930 |
Why?
|
| Anemia, Diamond-Blackfan | 13 | 2021 | 137 | 1.750 |
Why?
|
| Proto-Oncogene Proteins | 21 | 2024 | 4513 | 1.650 |
Why?
|
| Ubiquitination | 11 | 2024 | 1005 | 1.600 |
Why?
|
| Ribosomes | 6 | 2013 | 494 | 1.560 |
Why?
|
| Neoplastic Stem Cells | 10 | 2018 | 1348 | 1.550 |
Why?
|
| Clone Cells | 8 | 2019 | 1668 | 1.550 |
Why?
|
| Leukemia | 10 | 2022 | 1518 | 1.520 |
Why?
|
| Casein Kinase Ialpha | 5 | 2021 | 26 | 1.500 |
Why?
|
| Neoplasms, Second Primary | 7 | 2024 | 1052 | 1.460 |
Why?
|
| DNA-Binding Proteins | 31 | 2024 | 9566 | 1.450 |
Why?
|
| Anemia, Macrocytic | 7 | 2019 | 53 | 1.260 |
Why?
|
| Casein Kinase I | 4 | 2018 | 46 | 1.240 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 3 | 2022 | 269 | 1.230 |
Why?
|
| Chromosome Aberrations | 14 | 2024 | 1767 | 1.200 |
Why?
|
| Point Mutation | 7 | 2018 | 1593 | 1.200 |
Why?
|
| Blood | 3 | 2022 | 596 | 1.160 |
Why?
|
| Haploinsufficiency | 7 | 2022 | 336 | 1.150 |
Why?
|
| Multiple Myeloma | 10 | 2024 | 5145 | 1.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 13 | 2020 | 5666 | 1.070 |
Why?
|
| Spliceosomes | 3 | 2018 | 117 | 1.050 |
Why?
|
| Humans | 302 | 2024 | 761208 | 1.040 |
Why?
|
| Mice | 102 | 2024 | 81326 | 1.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2022 | 682 | 1.020 |
Why?
|
| Animals | 146 | 2024 | 168079 | 1.010 |
Why?
|
| Cell Cycle Proteins | 7 | 2024 | 3446 | 0.990 |
Why?
|
| Erythroid Precursor Cells | 6 | 2016 | 212 | 0.970 |
Why?
|
| Inflammasomes | 5 | 2024 | 526 | 0.970 |
Why?
|
| Erythroid Cells | 10 | 2017 | 237 | 0.940 |
Why?
|
| Transcription Factors | 18 | 2024 | 12099 | 0.930 |
Why?
|
| DNA Damage | 7 | 2023 | 2442 | 0.920 |
Why?
|
| Lymphoma, Non-Hodgkin | 3 | 2024 | 1372 | 0.910 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2015 | 774 | 0.870 |
Why?
|
| Bone Marrow Neoplasms | 2 | 2014 | 101 | 0.850 |
Why?
|
| Bone Marrow | 14 | 2023 | 2911 | 0.850 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2022 | 22 | 0.830 |
Why?
|
| Fetal Hemoglobin | 3 | 2015 | 345 | 0.820 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 2 | 2022 | 92 | 0.810 |
Why?
|
| Cell Transformation, Neoplastic | 11 | 2020 | 2820 | 0.810 |
Why?
|
| Peptide Termination Factors | 1 | 2022 | 56 | 0.800 |
Why?
|
| Atherosclerosis | 9 | 2024 | 3406 | 0.800 |
Why?
|
| Cyclins | 2 | 2023 | 594 | 0.780 |
Why?
|
| Polymerization | 2 | 2024 | 157 | 0.750 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2021 | 120 | 0.720 |
Why?
|
| RNA Interference | 8 | 2016 | 2816 | 0.720 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2021 | 77 | 0.720 |
Why?
|
| Hydroxyurea | 4 | 2015 | 284 | 0.700 |
Why?
|
| Primary Myelofibrosis | 5 | 2017 | 208 | 0.700 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 190 | 0.700 |
Why?
|
| Aging | 7 | 2024 | 8702 | 0.690 |
Why?
|
| Gene Deletion | 6 | 2020 | 2658 | 0.680 |
Why?
|
| Polycythemia Vera | 5 | 2013 | 161 | 0.680 |
Why?
|
| Anemia, Sickle Cell | 5 | 2015 | 1063 | 0.680 |
Why?
|
| Drug Resistance, Neoplasm | 10 | 2021 | 5300 | 0.680 |
Why?
|
| Cyclin-Dependent Kinase 9 | 2 | 2021 | 67 | 0.670 |
Why?
|
| RNA Splicing | 4 | 2021 | 896 | 0.670 |
Why?
|
| Giant Cell Arteritis | 1 | 2024 | 307 | 0.660 |
Why?
|
| Cell Differentiation | 22 | 2021 | 11509 | 0.660 |
Why?
|
| Genomics | 11 | 2023 | 5828 | 0.660 |
Why?
|
| Repressor Proteins | 11 | 2024 | 2974 | 0.660 |
Why?
|
| Antineoplastic Agents | 16 | 2023 | 13632 | 0.650 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 5 | 2024 | 305 | 0.640 |
Why?
|
| Neoplasms | 22 | 2022 | 22140 | 0.630 |
Why?
|
| Antisickling Agents | 3 | 2015 | 72 | 0.630 |
Why?
|
| Cardiovascular Diseases | 10 | 2024 | 15520 | 0.630 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2020 | 655 | 0.630 |
Why?
|
| Phosphoproteins | 6 | 2020 | 2444 | 0.620 |
Why?
|
| Cell Line, Tumor | 32 | 2023 | 16952 | 0.620 |
Why?
|
| src-Family Kinases | 1 | 2021 | 535 | 0.610 |
Why?
|
| Disease Models, Animal | 28 | 2024 | 18220 | 0.610 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2021 | 725 | 0.610 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2020 | 219 | 0.600 |
Why?
|
| Leukemia, Experimental | 2 | 2017 | 225 | 0.600 |
Why?
|
| Sequence Deletion | 7 | 2018 | 1487 | 0.600 |
Why?
|
| Erythroblasts | 2 | 2015 | 142 | 0.590 |
Why?
|
| Ikaros Transcription Factor | 4 | 2020 | 232 | 0.580 |
Why?
|
| Histone Deacetylase 2 | 2 | 2015 | 72 | 0.580 |
Why?
|
| Epigenesis, Genetic | 12 | 2021 | 3788 | 0.570 |
Why?
|
| Stem Cell Niche | 5 | 2016 | 345 | 0.570 |
Why?
|
| Chromatin | 3 | 2024 | 2946 | 0.560 |
Why?
|
| gamma-Globins | 2 | 2015 | 105 | 0.560 |
Why?
|
| Bone Marrow Cells | 10 | 2016 | 2410 | 0.560 |
Why?
|
| Histone Deacetylase 1 | 2 | 2015 | 133 | 0.550 |
Why?
|
| Nuclear Proteins | 14 | 2022 | 5782 | 0.550 |
Why?
|
| Cell Cycle | 5 | 2023 | 2925 | 0.550 |
Why?
|
| Purines | 1 | 2020 | 609 | 0.550 |
Why?
|
| Mutation, Missense | 7 | 2021 | 2567 | 0.550 |
Why?
|
| Calgranulin A | 2 | 2019 | 80 | 0.540 |
Why?
|
| DNA Mutational Analysis | 13 | 2020 | 4107 | 0.540 |
Why?
|
| Mice, Knockout | 18 | 2024 | 14392 | 0.540 |
Why?
|
| Selection, Genetic | 3 | 2020 | 871 | 0.530 |
Why?
|
| Pancytopenia | 2 | 2019 | 102 | 0.520 |
Why?
|
| Base Sequence | 18 | 2018 | 12404 | 0.520 |
Why?
|
| RNA Precursors | 2 | 2015 | 196 | 0.520 |
Why?
|
| Gene Expression Regulation | 20 | 2024 | 11856 | 0.510 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 86 | 0.510 |
Why?
|
| Ribonucleoproteins | 2 | 2015 | 356 | 0.510 |
Why?
|
| K562 Cells | 6 | 2021 | 640 | 0.510 |
Why?
|
| Genetic Predisposition to Disease | 16 | 2024 | 17897 | 0.510 |
Why?
|
| ARNTL Transcription Factors | 1 | 2016 | 96 | 0.500 |
Why?
|
| Calgranulin B | 1 | 2016 | 86 | 0.500 |
Why?
|
| Leucine | 3 | 2014 | 546 | 0.500 |
Why?
|
| HEK293 Cells | 12 | 2024 | 4243 | 0.500 |
Why?
|
| Gout | 1 | 2022 | 621 | 0.490 |
Why?
|
| Review Literature as Topic | 1 | 2017 | 348 | 0.480 |
Why?
|
| Prognosis | 26 | 2024 | 29687 | 0.480 |
Why?
|
| DNA Repair | 2 | 2022 | 2041 | 0.480 |
Why?
|
| Alleles | 7 | 2020 | 6857 | 0.480 |
Why?
|
| Erythropoietin | 13 | 2010 | 719 | 0.480 |
Why?
|
| Anemia | 4 | 2022 | 1504 | 0.470 |
Why?
|
| Ascorbic Acid | 1 | 2017 | 654 | 0.460 |
Why?
|
| Hodgkin Disease | 2 | 2024 | 1379 | 0.450 |
Why?
|
| Proteasome Endopeptidase Complex | 4 | 2024 | 1318 | 0.450 |
Why?
|
| HLA Antigens | 1 | 2019 | 1331 | 0.450 |
Why?
|
| Protein Kinase Inhibitors | 10 | 2019 | 5662 | 0.440 |
Why?
|
| Hematology | 1 | 2017 | 243 | 0.440 |
Why?
|
| Research Personnel | 1 | 2018 | 588 | 0.440 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 | 2024 | 1640 | 0.440 |
Why?
|
| Integrin beta3 | 2 | 2013 | 120 | 0.440 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2021 | 2455 | 0.440 |
Why?
|
| Mice, Mutant Strains | 6 | 2021 | 1751 | 0.430 |
Why?
|
| Transplantation, Autologous | 6 | 2024 | 2112 | 0.430 |
Why?
|
| ras Proteins | 3 | 2017 | 1055 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 20 | 2024 | 22127 | 0.410 |
Why?
|
| Telomere | 3 | 2020 | 939 | 0.410 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 | 2024 | 1549 | 0.410 |
Why?
|
| Proteins | 8 | 2024 | 5993 | 0.400 |
Why?
|
| Exons | 5 | 2019 | 2380 | 0.400 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 479 | 0.400 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2024 | 2897 | 0.400 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2021 | 2864 | 0.400 |
Why?
|
| MicroRNAs | 10 | 2020 | 3758 | 0.400 |
Why?
|
| Hemoglobin, Sickle | 1 | 2012 | 113 | 0.390 |
Why?
|
| Osteoporosis | 1 | 2021 | 1604 | 0.390 |
Why?
|
| Mosaicism | 3 | 2024 | 477 | 0.380 |
Why?
|
| Venous Thromboembolism | 1 | 2024 | 1869 | 0.380 |
Why?
|
| Lymphoma | 3 | 2021 | 1898 | 0.380 |
Why?
|
| Genes, Neurofibromatosis 1 | 2 | 2013 | 74 | 0.380 |
Why?
|
| Neoplasm Proteins | 4 | 2018 | 3594 | 0.370 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2012 | 3777 | 0.370 |
Why?
|
| Atrial Fibrillation | 3 | 2024 | 5114 | 0.370 |
Why?
|
| Pyridines | 2 | 2020 | 2872 | 0.360 |
Why?
|
| Molecular Targeted Therapy | 4 | 2021 | 2813 | 0.360 |
Why?
|
| STAT Transcription Factors | 4 | 2018 | 188 | 0.360 |
Why?
|
| Dexamethasone | 2 | 2011 | 1945 | 0.360 |
Why?
|
| Enzyme Inhibitors | 3 | 2018 | 3702 | 0.360 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2019 | 603 | 0.360 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2011 | 84 | 0.360 |
Why?
|
| Lipomatosis | 1 | 2011 | 112 | 0.360 |
Why?
|
| Small Molecule Libraries | 4 | 2020 | 731 | 0.360 |
Why?
|
| Signal Transduction | 17 | 2021 | 23416 | 0.360 |
Why?
|
| Amino Acid Substitution | 5 | 2013 | 1737 | 0.360 |
Why?
|
| Antigens, CD34 | 7 | 2017 | 655 | 0.360 |
Why?
|
| Ligands | 7 | 2023 | 3264 | 0.350 |
Why?
|
| Male | 74 | 2024 | 360693 | 0.350 |
Why?
|
| Gene Expression Profiling | 19 | 2016 | 9416 | 0.350 |
Why?
|
| Female | 76 | 2024 | 392544 | 0.340 |
Why?
|
| Aged | 45 | 2024 | 169288 | 0.340 |
Why?
|
| Quinazolines | 2 | 2017 | 1371 | 0.340 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 2021 | 176 | 0.340 |
Why?
|
| T-Lymphocytes | 7 | 2024 | 10203 | 0.340 |
Why?
|
| Bone Marrow Diseases | 1 | 2011 | 233 | 0.330 |
Why?
|
| Middle Aged | 51 | 2024 | 220853 | 0.330 |
Why?
|
| Hematologic Diseases | 1 | 2013 | 496 | 0.330 |
Why?
|
| Phenotype | 19 | 2023 | 16575 | 0.330 |
Why?
|
| Fanconi Anemia | 2 | 2023 | 324 | 0.330 |
Why?
|
| Isoxazoles | 9 | 1998 | 233 | 0.330 |
Why?
|
| Pyrimidines | 5 | 2019 | 3027 | 0.330 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2017 | 2047 | 0.320 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2021 | 8530 | 0.320 |
Why?
|
| Transcription, Genetic | 14 | 2020 | 7571 | 0.320 |
Why?
|
| Tumor Cells, Cultured | 15 | 2021 | 6124 | 0.320 |
Why?
|
| Anemia, Aplastic | 1 | 2011 | 230 | 0.310 |
Why?
|
| Genome, Human | 3 | 2020 | 4423 | 0.310 |
Why?
|
| Thrombosis | 2 | 2024 | 2944 | 0.310 |
Why?
|
| RNA, Small Interfering | 9 | 2017 | 3412 | 0.310 |
Why?
|
| Inflammation | 8 | 2023 | 10759 | 0.310 |
Why?
|
| Cryoelectron Microscopy | 2 | 2024 | 643 | 0.310 |
Why?
|
| Megakaryocytes | 7 | 2019 | 566 | 0.310 |
Why?
|
| Models, Biological | 11 | 2020 | 9457 | 0.300 |
Why?
|
| Cell Hypoxia | 10 | 2008 | 656 | 0.300 |
Why?
|
| Mesenchymal Stem Cells | 4 | 2017 | 1645 | 0.300 |
Why?
|
| Models, Molecular | 5 | 2024 | 5406 | 0.300 |
Why?
|
| Open Reading Frames | 1 | 2011 | 811 | 0.300 |
Why?
|
| Aminopyridines | 3 | 2022 | 573 | 0.300 |
Why?
|
| Janus Kinases | 4 | 2019 | 248 | 0.300 |
Why?
|
| DNA Modification Methylases | 2 | 2022 | 210 | 0.300 |
Why?
|
| Adult | 46 | 2024 | 221119 | 0.290 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 2018 | 0.290 |
Why?
|
| Protein Binding | 9 | 2024 | 9297 | 0.290 |
Why?
|
| Gene Dosage | 4 | 2017 | 1217 | 0.280 |
Why?
|
| Neoplasm, Residual | 4 | 2022 | 1008 | 0.280 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 3 | 2021 | 305 | 0.280 |
Why?
|
| Oncogene Proteins, Fusion | 6 | 2020 | 1605 | 0.280 |
Why?
|
| Transplantation, Homologous | 4 | 2020 | 4822 | 0.280 |
Why?
|
| Risk Factors | 22 | 2024 | 74239 | 0.280 |
Why?
|
| Survival Analysis | 8 | 2020 | 10088 | 0.280 |
Why?
|
| Cell Lineage | 9 | 2017 | 2548 | 0.280 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 1535 | 0.280 |
Why?
|
| Mice, Transgenic | 11 | 2024 | 9520 | 0.280 |
Why?
|
| Genes, p53 | 5 | 2022 | 713 | 0.280 |
Why?
|
| Telomerase | 1 | 2012 | 741 | 0.280 |
Why?
|
| Jurkat Cells | 2 | 2021 | 739 | 0.270 |
Why?
|
| Disease Susceptibility | 3 | 2023 | 1791 | 0.270 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 1743 | 0.270 |
Why?
|
| Transplantation Conditioning | 3 | 2020 | 1591 | 0.260 |
Why?
|
| Gene Silencing | 4 | 2014 | 1495 | 0.260 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2012 | 514 | 0.260 |
Why?
|
| Peptide Hydrolases | 3 | 2018 | 616 | 0.260 |
Why?
|
| Structure-Activity Relationship | 10 | 2024 | 3057 | 0.250 |
Why?
|
| RNA, Messenger | 9 | 2015 | 12747 | 0.250 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 4404 | 0.250 |
Why?
|
| Cell Proliferation | 14 | 2021 | 10422 | 0.250 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 3 | 2016 | 167 | 0.250 |
Why?
|
| Substrate Specificity | 3 | 2019 | 1768 | 0.250 |
Why?
|
| Interleukin-3 | 2 | 2022 | 425 | 0.240 |
Why?
|
| DNA Methylation | 4 | 2022 | 4384 | 0.240 |
Why?
|
| Flow Cytometry | 10 | 2024 | 5871 | 0.240 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2009 | 1057 | 0.240 |
Why?
|
| Genomic Instability | 3 | 2020 | 709 | 0.240 |
Why?
|
| Loss of Heterozygosity | 4 | 2024 | 662 | 0.240 |
Why?
|
| Leukemia, Myeloid | 3 | 2020 | 693 | 0.240 |
Why?
|
| Bone Marrow Transplantation | 5 | 2014 | 2692 | 0.230 |
Why?
|
| Cell Death | 3 | 2022 | 1676 | 0.230 |
Why?
|
| Drugs, Investigational | 2 | 2021 | 212 | 0.230 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2024 | 85 | 0.230 |
Why?
|
| Metabolic Diseases | 1 | 2011 | 680 | 0.230 |
Why?
|
| Phthalimides | 1 | 2024 | 34 | 0.230 |
Why?
|
| Apoptosis | 9 | 2023 | 9477 | 0.230 |
Why?
|
| Piperidones | 1 | 2024 | 37 | 0.230 |
Why?
|
| Receptors, AMPA | 8 | 1998 | 335 | 0.230 |
Why?
|
| Mevalonic Acid | 1 | 2024 | 46 | 0.220 |
Why?
|
| Mice, Inbred NOD | 5 | 2021 | 1822 | 0.220 |
Why?
|
| Lymphocytosis | 1 | 2024 | 121 | 0.220 |
Why?
|
| Molecular Sequence Data | 18 | 2015 | 17598 | 0.220 |
Why?
|
| Remission Induction | 3 | 2020 | 2392 | 0.220 |
Why?
|
| Cell Survival | 8 | 2020 | 5778 | 0.220 |
Why?
|
| Interleukin-7 | 1 | 2023 | 143 | 0.220 |
Why?
|
| Blood Platelet Disorders | 1 | 2023 | 60 | 0.210 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2023 | 2549 | 0.210 |
Why?
|
| Colchicine | 1 | 2024 | 258 | 0.210 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 3 | 2023 | 355 | 0.210 |
Why?
|
| Proteome | 4 | 2021 | 1856 | 0.210 |
Why?
|
| Biomedical Research | 1 | 2018 | 3434 | 0.210 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2021 | 3592 | 0.210 |
Why?
|
| Coronary Disease | 1 | 2017 | 5921 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2023 | 1404 | 0.210 |
Why?
|
| Azacitidine | 3 | 2014 | 336 | 0.200 |
Why?
|
| Blood Physiological Phenomena | 1 | 2022 | 53 | 0.200 |
Why?
|
| Macrophages | 5 | 2023 | 5753 | 0.200 |
Why?
|
| Germ-Line Mutation | 5 | 2023 | 1852 | 0.200 |
Why?
|
| Genetic Linkage | 1 | 2008 | 2340 | 0.200 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2023 | 411 | 0.200 |
Why?
|
| Allosteric Site | 1 | 2022 | 102 | 0.200 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2021 | 27 | 0.200 |
Why?
|
| Oncogenes | 2 | 2022 | 1220 | 0.200 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 1743 | 0.200 |
Why?
|
| L-Lactate Dehydrogenase | 3 | 1998 | 410 | 0.200 |
Why?
|
| Protein Stability | 2 | 2022 | 579 | 0.200 |
Why?
|
| Interleukin-5 | 1 | 2022 | 266 | 0.190 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2003 | 155 | 0.190 |
Why?
|
| Ubiquitins | 1 | 2023 | 366 | 0.190 |
Why?
|
| Cytarabine | 3 | 2019 | 697 | 0.190 |
Why?
|
| Mice, SCID | 4 | 2021 | 2621 | 0.190 |
Why?
|
| Septins | 1 | 2021 | 49 | 0.190 |
Why?
|
| Heart Failure | 3 | 2024 | 11701 | 0.190 |
Why?
|
| Cytogenetic Analysis | 2 | 2013 | 270 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 4 | 2023 | 367 | 0.190 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2023 | 1852 | 0.190 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2020 | 183 | 0.190 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2022 | 117 | 0.190 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2022 | 105 | 0.190 |
Why?
|
| B-Lymphocytes | 3 | 2024 | 4744 | 0.190 |
Why?
|
| Histones | 4 | 2017 | 2570 | 0.190 |
Why?
|
| Quantitative Trait Loci | 2 | 2019 | 2113 | 0.190 |
Why?
|
| Hepatitis | 1 | 2023 | 228 | 0.190 |
Why?
|
| Aged, 80 and over | 20 | 2024 | 58952 | 0.180 |
Why?
|
| Heme | 2 | 2013 | 313 | 0.180 |
Why?
|
| Gene Expression Regulation, Leukemic | 4 | 2022 | 651 | 0.180 |
Why?
|
| Mitochondria | 5 | 2019 | 3620 | 0.180 |
Why?
|
| Cell Line | 15 | 2022 | 15545 | 0.180 |
Why?
|
| RNA Helicases | 2 | 2020 | 142 | 0.180 |
Why?
|
| RNA-Binding Proteins | 3 | 2017 | 1855 | 0.180 |
Why?
|
| Cytokines | 6 | 2023 | 7386 | 0.180 |
Why?
|
| Morpholines | 1 | 2024 | 581 | 0.180 |
Why?
|
| Lysine | 2 | 2017 | 982 | 0.180 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2021 | 213 | 0.180 |
Why?
|
| U937 Cells | 1 | 2021 | 260 | 0.180 |
Why?
|
| Welding | 1 | 2021 | 89 | 0.180 |
Why?
|
| Blood Cell Count | 1 | 2021 | 396 | 0.180 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2023 | 856 | 0.180 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2022 | 307 | 0.180 |
Why?
|
| Splenic Neoplasms | 1 | 2021 | 94 | 0.180 |
Why?
|
| Carcinoma, Small Cell | 1 | 2003 | 420 | 0.180 |
Why?
|
| Homeodomain Proteins | 4 | 2019 | 2414 | 0.180 |
Why?
|
| Physicians | 1 | 2018 | 4584 | 0.180 |
Why?
|
| Alendronate | 1 | 2021 | 174 | 0.180 |
Why?
|
| Dipeptides | 1 | 2022 | 386 | 0.170 |
Why?
|
| Oncogene Proteins | 2 | 2021 | 718 | 0.170 |
Why?
|
| Young Adult | 17 | 2024 | 59221 | 0.170 |
Why?
|
| Cells, Cultured | 15 | 2021 | 18926 | 0.170 |
Why?
|
| DNA Repair Enzymes | 1 | 2022 | 346 | 0.170 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 382 | 0.170 |
Why?
|
| Dacarbazine | 1 | 2003 | 559 | 0.170 |
Why?
|
| Tissue Donors | 2 | 2020 | 2335 | 0.170 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2020 | 193 | 0.170 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 8 | 1998 | 70 | 0.170 |
Why?
|
| Interleukin-1beta | 2 | 2022 | 1002 | 0.170 |
Why?
|
| Solvents | 1 | 2020 | 294 | 0.170 |
Why?
|
| Anemia, Dyserythropoietic, Congenital | 1 | 2019 | 15 | 0.160 |
Why?
|
| Wills | 1 | 2019 | 13 | 0.160 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2021 | 178 | 0.160 |
Why?
|
| Menopause, Premature | 1 | 2020 | 124 | 0.160 |
Why?
|
| Polycyclic Compounds | 1 | 2019 | 29 | 0.160 |
Why?
|
| Nephrotic Syndrome | 1 | 2003 | 382 | 0.160 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2020 | 11733 | 0.160 |
Why?
|
| Enhancer Elements, Genetic | 6 | 1998 | 1360 | 0.160 |
Why?
|
| Computational Biology | 3 | 2015 | 3499 | 0.160 |
Why?
|
| Genotype | 6 | 2021 | 12985 | 0.160 |
Why?
|
| Lung Neoplasms | 6 | 2022 | 13385 | 0.160 |
Why?
|
| Mass Spectrometry | 3 | 2020 | 2189 | 0.160 |
Why?
|
| Ferritins | 1 | 2022 | 596 | 0.160 |
Why?
|
| Gene Expression | 6 | 2016 | 7571 | 0.160 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 890 | 0.160 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2003 | 617 | 0.160 |
Why?
|
| Disease Management | 3 | 2019 | 2507 | 0.160 |
Why?
|
| RNA, Neoplasm | 3 | 2020 | 748 | 0.160 |
Why?
|
| Air Pollutants, Occupational | 1 | 2021 | 407 | 0.160 |
Why?
|
| Serine | 1 | 2022 | 826 | 0.150 |
Why?
|
| Synthetic Biology | 1 | 2020 | 185 | 0.150 |
Why?
|
| Role | 1 | 2018 | 176 | 0.150 |
Why?
|
| Lactams | 1 | 2019 | 156 | 0.150 |
Why?
|
| Phthalazines | 1 | 2021 | 383 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2010 | 1132 | 0.150 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2024 | 1468 | 0.150 |
Why?
|
| Chemokine CXCL12 | 1 | 2020 | 454 | 0.150 |
Why?
|
| Myofibroblasts | 2 | 2017 | 223 | 0.150 |
Why?
|
| GATA1 Transcription Factor | 1 | 2019 | 296 | 0.150 |
Why?
|
| Etoposide | 4 | 2019 | 635 | 0.150 |
Why?
|
| DNA Primers | 4 | 2014 | 2814 | 0.150 |
Why?
|
| Duane Retraction Syndrome | 1 | 2018 | 59 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 5 | 2018 | 4739 | 0.150 |
Why?
|
| Osteoclasts | 1 | 2021 | 711 | 0.150 |
Why?
|
| Survival Rate | 6 | 2022 | 12728 | 0.150 |
Why?
|
| Receptors, GABA-A | 2 | 2001 | 621 | 0.150 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2021 | 386 | 0.150 |
Why?
|
| Immune System | 1 | 2023 | 792 | 0.140 |
Why?
|
| Blotting, Western | 4 | 2016 | 5032 | 0.140 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2018 | 199 | 0.140 |
Why?
|
| Hydrolases | 1 | 2018 | 146 | 0.140 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 1996 | 436 | 0.140 |
Why?
|
| Hydrazones | 1 | 2017 | 103 | 0.140 |
Why?
|
| Disease Progression | 8 | 2023 | 13511 | 0.140 |
Why?
|
| Zygote | 1 | 2017 | 115 | 0.140 |
Why?
|
| Case-Control Studies | 6 | 2022 | 22174 | 0.140 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2017 | 69 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 3 | 2015 | 6067 | 0.140 |
Why?
|
| Stem Cells | 4 | 2023 | 3517 | 0.140 |
Why?
|
| Alternative Splicing | 2 | 2019 | 1087 | 0.140 |
Why?
|
| Excitatory Amino Acid Agonists | 4 | 1998 | 142 | 0.140 |
Why?
|
| Stromal Cells | 3 | 2011 | 1329 | 0.140 |
Why?
|
| Colony-Forming Units Assay | 5 | 2020 | 351 | 0.140 |
Why?
|
| Interleukins | 1 | 2021 | 782 | 0.140 |
Why?
|
| Genes, Dominant | 1 | 2019 | 850 | 0.140 |
Why?
|
| Immunity, Innate | 4 | 2023 | 3044 | 0.140 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2023 | 695 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2019 | 316 | 0.130 |
Why?
|
| DNA Helicases | 2 | 2020 | 850 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2019 | 15920 | 0.130 |
Why?
|
| Neutropenia | 1 | 2021 | 885 | 0.130 |
Why?
|
| Species Specificity | 3 | 2018 | 2406 | 0.130 |
Why?
|
| Introns | 1 | 2019 | 968 | 0.130 |
Why?
|
| Uric Acid | 1 | 2022 | 807 | 0.130 |
Why?
|
| Histone Demethylases | 1 | 2019 | 322 | 0.130 |
Why?
|
| Alanine | 3 | 1998 | 608 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 1602 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 5 | 2012 | 6199 | 0.130 |
Why?
|
| Germ Cells | 1 | 2020 | 632 | 0.130 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 7 | 2006 | 619 | 0.130 |
Why?
|
| Disasters | 1 | 2022 | 520 | 0.130 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2019 | 544 | 0.130 |
Why?
|
| Gene Knockout Techniques | 2 | 2016 | 801 | 0.130 |
Why?
|
| Treatment Outcome | 11 | 2020 | 64681 | 0.130 |
Why?
|
| Receptors, CXCR4 | 1 | 2020 | 727 | 0.120 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2014 | 20 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2018 | 348 | 0.120 |
Why?
|
| Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
| Eosinophilia | 1 | 2020 | 557 | 0.120 |
Why?
|
| Lentivirus | 2 | 2015 | 508 | 0.120 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2014 | 33 | 0.120 |
Why?
|
| Myocytes, Cardiac | 1 | 2024 | 1666 | 0.120 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2016 | 714 | 0.120 |
Why?
|
| Ubiquitin | 1 | 2020 | 839 | 0.120 |
Why?
|
| Genome | 3 | 2023 | 1738 | 0.120 |
Why?
|
| Methylation | 1 | 2017 | 1070 | 0.120 |
Why?
|
| Myeloid Progenitor Cells | 2 | 2017 | 112 | 0.120 |
Why?
|
| beta-Globins | 1 | 2015 | 111 | 0.120 |
Why?
|
| Protein Conformation | 2 | 2022 | 3933 | 0.120 |
Why?
|
| Mutagenesis, Insertional | 1 | 2017 | 657 | 0.120 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2015 | 251 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2003 | 5321 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2016 | 2468 | 0.120 |
Why?
|
| Antigens, Nuclear | 1 | 2014 | 184 | 0.120 |
Why?
|
| Histocompatibility Antigens | 1 | 2015 | 467 | 0.110 |
Why?
|
| Genes, ras | 1 | 2017 | 654 | 0.110 |
Why?
|
| Protein Biosynthesis | 3 | 2012 | 2091 | 0.110 |
Why?
|
| Ribosomal Protein S6 | 1 | 2014 | 71 | 0.110 |
Why?
|
| Africa | 2 | 2020 | 714 | 0.110 |
Why?
|
| Heart Arrest | 1 | 2024 | 1513 | 0.110 |
Why?
|
| Protein Multimerization | 2 | 2024 | 974 | 0.110 |
Why?
|
| HeLa Cells | 8 | 2020 | 3073 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2014 | 361 | 0.110 |
Why?
|
| Age of Onset | 1 | 2020 | 3307 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1225 | 0.110 |
Why?
|
| Microscopy, Confocal | 3 | 2016 | 1967 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 987 | 0.110 |
Why?
|
| Cancer Vaccines | 1 | 2021 | 1038 | 0.110 |
Why?
|
| Amino Acid Sequence | 5 | 2018 | 13402 | 0.110 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2013 | 86 | 0.110 |
Why?
|
| Benzothiazoles | 2 | 2012 | 248 | 0.110 |
Why?
|
| Oxygen | 7 | 2008 | 4227 | 0.110 |
Why?
|
| GTP-Binding Proteins | 2 | 2014 | 946 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 5 | 2019 | 5773 | 0.110 |
Why?
|
| Tumor Microenvironment | 2 | 2019 | 3873 | 0.110 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2015 | 179 | 0.110 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2013 | 81 | 0.100 |
Why?
|
| Nitriles | 1 | 2018 | 971 | 0.100 |
Why?
|
| Communicable Diseases | 1 | 2021 | 873 | 0.100 |
Why?
|
| Adolescent | 13 | 2024 | 88298 | 0.100 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 2 | 2024 | 263 | 0.100 |
Why?
|
| Thiazoles | 3 | 2014 | 1517 | 0.100 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 1932 | 0.100 |
Why?
|
| Mastocytosis, Systemic | 1 | 2014 | 102 | 0.100 |
Why?
|
| Hematocrit | 2 | 2013 | 623 | 0.100 |
Why?
|
| Syndrome | 2 | 2010 | 3271 | 0.100 |
Why?
|
| DNA Copy Number Variations | 3 | 2024 | 2024 | 0.100 |
Why?
|
| Recurrence | 3 | 2022 | 8457 | 0.100 |
Why?
|
| alpha-Globins | 1 | 2012 | 19 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2018 | 1567 | 0.100 |
Why?
|
| Gene Frequency | 2 | 2020 | 3603 | 0.100 |
Why?
|
| Isoenzymes | 2 | 1996 | 1682 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1935 | 0.100 |
Why?
|
| Transplantation Chimera | 1 | 2014 | 594 | 0.100 |
Why?
|
| Up-Regulation | 3 | 2012 | 4111 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1 | 6 | 1998 | 193 | 0.100 |
Why?
|
| Coronary Artery Disease | 2 | 2022 | 6505 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 504 | 0.100 |
Why?
|
| Leukocytes | 1 | 2020 | 2025 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 736 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2022 | 2803 | 0.100 |
Why?
|
| Receptors, GABA | 1 | 2013 | 312 | 0.100 |
Why?
|
| Phosphorylation | 6 | 2014 | 8300 | 0.100 |
Why?
|
| Postmenopause | 1 | 2020 | 2514 | 0.090 |
Why?
|
| Medical Oncology | 2 | 2020 | 2320 | 0.090 |
Why?
|
| Pimozide | 1 | 2011 | 21 | 0.090 |
Why?
|
| Genome-Wide Association Study | 6 | 2021 | 12676 | 0.090 |
Why?
|
| Glutarates | 1 | 2013 | 243 | 0.090 |
Why?
|
| Toluene | 1 | 2010 | 32 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2016 | 2058 | 0.090 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2011 | 104 | 0.090 |
Why?
|
| Gene Targeting | 1 | 2014 | 838 | 0.090 |
Why?
|
| Sequence Alignment | 1 | 2015 | 2175 | 0.090 |
Why?
|
| Pyrazoles | 2 | 2019 | 2010 | 0.090 |
Why?
|
| Response Elements | 2 | 2010 | 306 | 0.090 |
Why?
|
| Zebrafish Proteins | 2 | 2014 | 1012 | 0.090 |
Why?
|
| Megakaryocyte-Erythroid Progenitor Cells | 1 | 2010 | 10 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2021 | 1814 | 0.090 |
Why?
|
| Neoplasm Transplantation | 5 | 2016 | 2010 | 0.090 |
Why?
|
| Genetic Vectors | 3 | 2017 | 3388 | 0.090 |
Why?
|
| Megakaryocyte Progenitor Cells | 1 | 2010 | 28 | 0.090 |
Why?
|
| beta-Thalassemia | 1 | 2013 | 236 | 0.090 |
Why?
|
| Hemoglobins | 2 | 2013 | 1525 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2018 | 2765 | 0.090 |
Why?
|
| Treatment Failure | 2 | 2014 | 2643 | 0.090 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2019 | 495 | 0.090 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2010 | 37 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2021 | 2131 | 0.090 |
Why?
|
| Cell Nucleolus | 1 | 2010 | 153 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 726 | 0.090 |
Why?
|
| Uniparental Disomy | 1 | 2010 | 45 | 0.090 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2010 | 151 | 0.090 |
Why?
|
| STAT5 Transcription Factor | 1 | 2011 | 266 | 0.090 |
Why?
|
| Hospitals | 1 | 2023 | 3881 | 0.090 |
Why?
|
| Cobalt | 5 | 1996 | 148 | 0.090 |
Why?
|
| Prostaglandin D2 | 1 | 2010 | 108 | 0.090 |
Why?
|
| Tissue Scaffolds | 2 | 2016 | 932 | 0.080 |
Why?
|
| Antigens, CD | 2 | 2010 | 4009 | 0.080 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 517 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 2509 | 0.080 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 575 | 0.080 |
Why?
|
| Binding Sites | 4 | 2024 | 5988 | 0.080 |
Why?
|
| Transfection | 6 | 2019 | 5748 | 0.080 |
Why?
|
| Sulfonamides | 3 | 2022 | 1977 | 0.080 |
Why?
|
| Drosophila melanogaster | 2 | 2015 | 1710 | 0.080 |
Why?
|
| Pneumonia | 1 | 2021 | 2142 | 0.080 |
Why?
|
| Cytoplasmic Granules | 1 | 2012 | 573 | 0.080 |
Why?
|
| Interleukin-2 | 2 | 2013 | 1891 | 0.080 |
Why?
|
| Piperidines | 2 | 2019 | 1656 | 0.080 |
Why?
|
| Risk | 2 | 2021 | 9616 | 0.080 |
Why?
|
| Organ Specificity | 4 | 2015 | 1963 | 0.080 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2010 | 181 | 0.080 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2008 | 18 | 0.080 |
Why?
|
| Vitamins | 1 | 2017 | 1634 | 0.080 |
Why?
|
| World Health Organization | 3 | 2022 | 1321 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2017 | 1050 | 0.080 |
Why?
|
| Follow-Up Studies | 5 | 2022 | 39126 | 0.080 |
Why?
|
| Immunologic Factors | 2 | 2015 | 1589 | 0.080 |
Why?
|
| Mitoxantrone | 2 | 2019 | 148 | 0.080 |
Why?
|
| Interferon-alpha | 1 | 2013 | 907 | 0.080 |
Why?
|
| Trans-Activators | 1 | 1998 | 2846 | 0.080 |
Why?
|
| Deferoxamine | 4 | 1996 | 155 | 0.080 |
Why?
|
| Pyrrolidines | 1 | 2010 | 339 | 0.080 |
Why?
|
| Cell Division | 2 | 2014 | 4451 | 0.080 |
Why?
|
| Luciferases | 2 | 2012 | 710 | 0.080 |
Why?
|
| Health Status | 1 | 2021 | 4077 | 0.080 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2016 | 464 | 0.080 |
Why?
|
| NF-kappa B | 3 | 2018 | 2475 | 0.080 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2008 | 55 | 0.080 |
Why?
|
| beta Catenin | 1 | 2013 | 1042 | 0.070 |
Why?
|
| Lymphoma, B-Cell | 1 | 2014 | 938 | 0.070 |
Why?
|
| Stereoisomerism | 7 | 1999 | 611 | 0.070 |
Why?
|
| Prevalence | 3 | 2021 | 15721 | 0.070 |
Why?
|
| Lipids | 1 | 2018 | 3331 | 0.070 |
Why?
|
| 5' Untranslated Regions | 1 | 2008 | 251 | 0.070 |
Why?
|
| Fibrosis | 1 | 2014 | 2051 | 0.070 |
Why?
|
| Molecular Structure | 6 | 2024 | 1875 | 0.070 |
Why?
|
| Embryonic Development | 1 | 2012 | 719 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2012 | 1838 | 0.070 |
Why?
|
| Casein Kinase II | 1 | 2007 | 122 | 0.070 |
Why?
|
| Drug Approval | 1 | 2014 | 812 | 0.070 |
Why?
|
| Coculture Techniques | 1 | 2011 | 1334 | 0.070 |
Why?
|
| Sepsis | 1 | 2021 | 2585 | 0.070 |
Why?
|
| Rats | 16 | 2019 | 23704 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2020 | 3092 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3201 | 0.070 |
Why?
|
| RNA, Ribosomal | 1 | 2008 | 223 | 0.070 |
Why?
|
| Risk Assessment | 4 | 2024 | 24021 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 1 | 2013 | 794 | 0.070 |
Why?
|
| Glioma | 1 | 2022 | 3452 | 0.070 |
Why?
|
| Prospective Studies | 6 | 2024 | 54435 | 0.070 |
Why?
|
| Mitochondrial Proteins | 1 | 2012 | 974 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4567 | 0.070 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2013 | 937 | 0.070 |
Why?
|
| Spleen | 2 | 2010 | 2290 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2015 | 1375 | 0.070 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2007 | 159 | 0.070 |
Why?
|
| Cell Count | 1 | 2010 | 1831 | 0.070 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 686 | 0.060 |
Why?
|
| Tissue Engineering | 1 | 2016 | 1865 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2010 | 4574 | 0.060 |
Why?
|
| Heterozygote | 2 | 2010 | 2778 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1695 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 2 | 2023 | 368 | 0.060 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2008 | 628 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2012 | 15308 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 1141 | 0.060 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 1999 | 790 | 0.060 |
Why?
|
| Drug Therapy, Combination | 2 | 2014 | 6304 | 0.060 |
Why?
|
| Proline | 1 | 2006 | 455 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 1996 | 2877 | 0.060 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 4612 | 0.060 |
Why?
|
| Homeostasis | 2 | 2014 | 3320 | 0.060 |
Why?
|
| Stem Cell Factor | 1 | 2005 | 195 | 0.060 |
Why?
|
| Imidazoles | 1 | 2010 | 1172 | 0.060 |
Why?
|
| Piperazines | 2 | 2016 | 2522 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 2569 | 0.060 |
Why?
|
| RNA | 1 | 2014 | 2709 | 0.060 |
Why?
|
| Genetic Testing | 2 | 2016 | 3537 | 0.060 |
Why?
|
| Algorithms | 2 | 2019 | 14025 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 1996 | 894 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2024 | 10756 | 0.060 |
Why?
|
| Pedigree | 1 | 2012 | 4537 | 0.060 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 1391 | 0.060 |
Why?
|
| Genetic Complementation Test | 2 | 2017 | 556 | 0.060 |
Why?
|
| Protoporphyrins | 2 | 2003 | 168 | 0.060 |
Why?
|
| Synapses | 1 | 2013 | 1755 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 6819 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6486 | 0.060 |
Why?
|
| Thrombocythemia, Essential | 1 | 2005 | 113 | 0.060 |
Why?
|
| Child | 7 | 2023 | 80152 | 0.060 |
Why?
|
| Acetates | 2 | 1996 | 319 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2021 | 2871 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2005 | 864 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1651 | 0.050 |
Why?
|
| Dimerization | 2 | 2019 | 887 | 0.050 |
Why?
|
| Diet | 1 | 2021 | 8048 | 0.050 |
Why?
|
| HIV | 1 | 2010 | 1581 | 0.050 |
Why?
|
| Glucose | 1 | 2015 | 4342 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 20119 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2015 | 3313 | 0.050 |
Why?
|
| Esophagus | 2 | 2014 | 1036 | 0.050 |
Why?
|
| Frameshift Mutation | 2 | 2019 | 392 | 0.050 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 12976 | 0.050 |
Why?
|
| Azepines | 1 | 2024 | 328 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2021 | 12474 | 0.050 |
Why?
|
| Retroviridae | 1 | 2005 | 850 | 0.050 |
Why?
|
| Single-Cell Analysis | 3 | 2021 | 2451 | 0.050 |
Why?
|
| Bradycardia | 1 | 2024 | 298 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2011 | 2916 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 11067 | 0.050 |
Why?
|
| Tetraploidy | 1 | 2021 | 28 | 0.050 |
Why?
|
| Proteoglycans | 2 | 2016 | 803 | 0.050 |
Why?
|
| Stem Cell Transplantation | 2 | 2023 | 1600 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2012 | 4935 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2008 | 1361 | 0.050 |
Why?
|
| Genetic Markers | 1 | 2008 | 2599 | 0.050 |
Why?
|
| Infant | 4 | 2022 | 36169 | 0.050 |
Why?
|
| Cluster Analysis | 3 | 2015 | 2706 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 9025 | 0.050 |
Why?
|
| Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
| Caspases, Initiator | 1 | 2021 | 31 | 0.050 |
Why?
|
| GABA Antagonists | 1 | 2001 | 119 | 0.050 |
Why?
|
| Age Factors | 2 | 2015 | 18384 | 0.050 |
Why?
|
| GABA Agonists | 1 | 2001 | 104 | 0.050 |
Why?
|
| alpha Karyopherins | 1 | 2020 | 40 | 0.050 |
Why?
|
| Homozygote | 3 | 2014 | 1775 | 0.050 |
Why?
|
| Carbocyanines | 1 | 2001 | 175 | 0.050 |
Why?
|
| Fusion Proteins, bcr-abl | 2 | 2014 | 430 | 0.050 |
Why?
|
| Fanconi Anemia Complementation Group A Protein | 1 | 2020 | 50 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 2731 | 0.040 |
Why?
|
| Gases | 1 | 2021 | 204 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2011 | 4137 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 1812 | 0.040 |
Why?
|
| Proteinuria | 1 | 2003 | 605 | 0.040 |
Why?
|
| North America | 1 | 2024 | 1284 | 0.040 |
Why?
|
| Iron | 1 | 2008 | 1790 | 0.040 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2021 | 92 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2021 | 226 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2023 | 9652 | 0.040 |
Why?
|
| Consensus | 2 | 2022 | 3134 | 0.040 |
Why?
|
| Zebrafish | 3 | 2020 | 3000 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 11119 | 0.040 |
Why?
|
| Calmodulin | 1 | 2020 | 217 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2008 | 1882 | 0.040 |
Why?
|
| Brain Stem Neoplasms | 1 | 2022 | 189 | 0.040 |
Why?
|
| Molecular Biology | 1 | 2023 | 573 | 0.040 |
Why?
|
| Pentanoic Acids | 1 | 1999 | 16 | 0.040 |
Why?
|
| Logistic Models | 1 | 2014 | 13249 | 0.040 |
Why?
|
| Digestive System Diseases | 1 | 2021 | 151 | 0.040 |
Why?
|
| Genetic Fitness | 1 | 2020 | 118 | 0.040 |
Why?
|
| GABA Agents | 1 | 1999 | 41 | 0.040 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 299 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2017 | 1518 | 0.040 |
Why?
|
| Dizocilpine Maleate | 3 | 1994 | 172 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2010 | 2568 | 0.040 |
Why?
|
| Xenopus | 1 | 2001 | 709 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2008 | 1168 | 0.040 |
Why?
|
| Troponin T | 1 | 2024 | 780 | 0.040 |
Why?
|
| Dust | 1 | 2022 | 486 | 0.040 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2020 | 323 | 0.040 |
Why?
|
| Triazoles | 1 | 2024 | 902 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 8519 | 0.040 |
Why?
|
| Crystallography, X-Ray | 4 | 1998 | 1978 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12052 | 0.040 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2018 | 12 | 0.040 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 1998 | 446 | 0.040 |
Why?
|
| Activating Transcription Factor 1 | 1 | 1998 | 26 | 0.040 |
Why?
|
| Barrett Esophagus | 1 | 2003 | 492 | 0.040 |
Why?
|
| Mutant Proteins | 2 | 2013 | 489 | 0.040 |
Why?
|
| Enzyme Activation | 3 | 2012 | 3577 | 0.040 |
Why?
|
| Models, Genetic | 2 | 2007 | 3430 | 0.040 |
Why?
|
| Baclofen | 1 | 1999 | 120 | 0.040 |
Why?
|
| Polycythemia | 1 | 1999 | 124 | 0.040 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2019 | 98 | 0.040 |
Why?
|
| Child, Preschool | 5 | 2022 | 42224 | 0.040 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2018 | 32 | 0.040 |
Why?
|
| Inhalation Exposure | 1 | 2021 | 432 | 0.040 |
Why?
|
| Receptors, Metabotropic Glutamate | 2 | 1998 | 195 | 0.040 |
Why?
|
| Phosphoglycerate Kinase | 2 | 1996 | 66 | 0.040 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 255 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2024 | 80674 | 0.040 |
Why?
|
| Myeloid Cells | 2 | 2018 | 822 | 0.040 |
Why?
|
| Calcium Chloride | 1 | 1998 | 78 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2020 | 332 | 0.040 |
Why?
|
| CREB-Binding Protein | 1 | 1998 | 146 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2019 | 370 | 0.040 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2019 | 163 | 0.040 |
Why?
|
| Caspase 8 | 1 | 2018 | 190 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 210 | 0.040 |
Why?
|
| Teratogens | 1 | 2018 | 117 | 0.040 |
Why?
|
| Japan | 1 | 2022 | 1378 | 0.040 |
Why?
|
| Kainic Acid | 2 | 1997 | 203 | 0.040 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2019 | 238 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2001 | 940 | 0.040 |
Why?
|
| Aortic Diseases | 1 | 2023 | 735 | 0.040 |
Why?
|
| Allyl Compounds | 1 | 2017 | 22 | 0.040 |
Why?
|
| HIV Infections | 1 | 2024 | 17347 | 0.040 |
Why?
|
| Receptors, Glutamate | 1 | 1998 | 227 | 0.040 |
Why?
|
| Granulocytes | 2 | 2012 | 550 | 0.040 |
Why?
|
| Mice, Nude | 3 | 2012 | 3605 | 0.040 |
Why?
|
| Leukemia, Biphenotypic, Acute | 1 | 2017 | 32 | 0.040 |
Why?
|
| Furans | 1 | 1998 | 201 | 0.040 |
Why?
|
| Karyotyping | 1 | 2019 | 1172 | 0.030 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2016 | 49 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 2 | 2015 | 2011 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2019 | 629 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2022 | 1125 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2020 | 1967 | 0.030 |
Why?
|
| Kinetics | 2 | 2021 | 6312 | 0.030 |
Why?
|
| Benzimidazoles | 1 | 2022 | 858 | 0.030 |
Why?
|
| Demography | 1 | 2021 | 1641 | 0.030 |
Why?
|
| DNA | 2 | 2023 | 7189 | 0.030 |
Why?
|
| Oocytes | 1 | 2001 | 1165 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7851 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1624 | 0.030 |
Why?
|
| Glycine | 3 | 1994 | 659 | 0.030 |
Why?
|
| Rotenone | 1 | 1995 | 45 | 0.030 |
Why?
|
| Onium Compounds | 1 | 1995 | 27 | 0.030 |
Why?
|
| Globins | 1 | 2017 | 405 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2020 | 465 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2021 | 26199 | 0.030 |
Why?
|
| Ibotenic Acid | 2 | 1992 | 59 | 0.030 |
Why?
|
| Arecoline | 1 | 1995 | 9 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2001 | 740 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 2426 | 0.030 |
Why?
|
| Sensitivity and Specificity | 4 | 2020 | 14675 | 0.030 |
Why?
|
| Hemolymph | 1 | 2015 | 27 | 0.030 |
Why?
|
| Siderophores | 1 | 1996 | 61 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 416 | 0.030 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2015 | 110 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 780 | 0.030 |
Why?
|
| Fat Body | 1 | 2015 | 31 | 0.030 |
Why?
|
| Mammography | 1 | 2006 | 2430 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2020 | 1080 | 0.030 |
Why?
|
| Glucose Transporter Type 1 | 1 | 1995 | 185 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2005 | 2159 | 0.030 |
Why?
|
| Blood Vessels | 2 | 2014 | 1111 | 0.030 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2018 | 451 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2017 | 883 | 0.030 |
Why?
|
| Smoking | 2 | 2022 | 9055 | 0.030 |
Why?
|
| Melanoma | 1 | 2013 | 5694 | 0.030 |
Why?
|
| Muscarinic Agonists | 1 | 1995 | 91 | 0.030 |
Why?
|
| Brain | 7 | 2013 | 27092 | 0.030 |
Why?
|
| Trehalose | 1 | 2015 | 88 | 0.030 |
Why?
|
| Birth Weight | 1 | 2023 | 2104 | 0.030 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 20982 | 0.030 |
Why?
|
| Calcium Phosphates | 1 | 2016 | 171 | 0.030 |
Why?
|
| Incidence | 2 | 2024 | 21365 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1995 | 818 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2023 | 1885 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2001 | 1535 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2024 | 41496 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 1838 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2016 | 352 | 0.030 |
Why?
|
| Electrophysiology | 4 | 1998 | 1262 | 0.030 |
Why?
|
| Hospitalization | 1 | 2014 | 10707 | 0.030 |
Why?
|
| Laminin | 1 | 2016 | 407 | 0.030 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 226 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 734 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2024 | 3210 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 262 | 0.030 |
Why?
|
| Multipotent Stem Cells | 1 | 2015 | 200 | 0.030 |
Why?
|
| Heterocyclic Compounds | 1 | 1995 | 245 | 0.030 |
Why?
|
| Binding, Competitive | 4 | 1999 | 1140 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 1078 | 0.030 |
Why?
|
| Drug Partial Agonism | 1 | 2013 | 24 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2008 | 2421 | 0.030 |
Why?
|
| Diphtheria Toxin | 1 | 2014 | 253 | 0.030 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2013 | 122 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 2635 | 0.030 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2013 | 29 | 0.030 |
Why?
|
| Chelating Agents | 1 | 1995 | 383 | 0.030 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2013 | 48 | 0.030 |
Why?
|
| raf Kinases | 1 | 2013 | 118 | 0.030 |
Why?
|
| Lovastatin | 1 | 2013 | 115 | 0.030 |
Why?
|
| Mediator Complex | 1 | 2013 | 106 | 0.030 |
Why?
|
| Clodronic Acid | 1 | 2013 | 58 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 168 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 1985 | 0.030 |
Why?
|
| Adenine | 1 | 2019 | 986 | 0.030 |
Why?
|
| Calreticulin | 1 | 2014 | 113 | 0.030 |
Why?
|
| Cerebral Cortex | 5 | 1997 | 5775 | 0.030 |
Why?
|
| Receptors, Amino Acid | 1 | 1992 | 30 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2001 | 1901 | 0.030 |
Why?
|
| Growth Substances | 1 | 1995 | 759 | 0.030 |
Why?
|
| Ferrochelatase | 1 | 2012 | 47 | 0.030 |
Why?
|
| Antibodies | 1 | 2021 | 2415 | 0.030 |
Why?
|
| Erythrocyte Count | 1 | 2013 | 157 | 0.030 |
Why?
|
| Cullin Proteins | 1 | 2013 | 180 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2019 | 2224 | 0.030 |
Why?
|
| Tyrphostins | 1 | 2012 | 63 | 0.030 |
Why?
|
| TYK2 Kinase | 1 | 2012 | 38 | 0.030 |
Why?
|
| Receptors, Kainic Acid | 3 | 1997 | 90 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 620 | 0.030 |
Why?
|
| Corpus Callosum | 1 | 1997 | 750 | 0.030 |
Why?
|
| Esophageal Neoplasms | 1 | 2003 | 1658 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2016 | 2561 | 0.030 |
Why?
|
| Janus Kinase 1 | 1 | 2012 | 107 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1995 | 1681 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2024 | 3821 | 0.030 |
Why?
|
| Reticulocytes | 1 | 2013 | 288 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 2138 | 0.020 |
Why?
|
| Blast Crisis | 1 | 2012 | 102 | 0.020 |
Why?
|
| Streptococcus pyogenes | 1 | 2014 | 292 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2024 | 4420 | 0.020 |
Why?
|
| Pericytes | 1 | 2014 | 294 | 0.020 |
Why?
|
| Anemia, Sideroblastic | 1 | 2012 | 109 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2016 | 1867 | 0.020 |
Why?
|
| Acute Disease | 1 | 2022 | 7226 | 0.020 |
Why?
|
| Glycolysis | 1 | 1996 | 836 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2393 | 0.020 |
Why?
|
| Echocardiography | 1 | 2024 | 5006 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2013 | 364 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 874 | 0.020 |
Why?
|
| eIF-2 Kinase | 1 | 2012 | 145 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 502 | 0.020 |
Why?
|
| N-Methylaspartate | 3 | 1997 | 230 | 0.020 |
Why?
|
| Molecular Conformation | 3 | 1998 | 543 | 0.020 |
Why?
|
| Valine | 1 | 2013 | 408 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2018 | 1246 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 1997 | 1173 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2013 | 344 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2014 | 603 | 0.020 |
Why?
|
| Recombination, Genetic | 2 | 2006 | 1518 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2017 | 1264 | 0.020 |
Why?
|
| Women's Health | 1 | 2020 | 2070 | 0.020 |
Why?
|
| Gene Library | 1 | 2013 | 1054 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2018 | 1423 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2014 | 748 | 0.020 |
Why?
|
| Serpins | 1 | 2012 | 247 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 1995 | 1007 | 0.020 |
Why?
|
| Sex Factors | 1 | 2024 | 10553 | 0.020 |
Why?
|
| Time Factors | 3 | 2013 | 39957 | 0.020 |
Why?
|
| Tomography | 1 | 2012 | 411 | 0.020 |
Why?
|
| Muscles | 1 | 2015 | 1568 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2013 | 1088 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 848 | 0.020 |
Why?
|
| International Cooperation | 1 | 2016 | 1423 | 0.020 |
Why?
|
| Propionates | 1 | 1991 | 181 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2013 | 696 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2013 | 8164 | 0.020 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2010 | 139 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2016 | 3091 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1703 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2021 | 2726 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2019 | 2413 | 0.020 |
Why?
|
| Sarcoma, Myeloid | 1 | 2010 | 52 | 0.020 |
Why?
|
| Stomach | 1 | 2014 | 697 | 0.020 |
Why?
|
| Codon, Terminator | 1 | 2010 | 124 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2016 | 2048 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2012 | 422 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2003 | 683 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 8998 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2013 | 962 | 0.020 |
Why?
|
| Hematinics | 1 | 2012 | 282 | 0.020 |
Why?
|
| Endothelial Cells | 2 | 2014 | 3551 | 0.020 |
Why?
|
| Iron-Regulatory Proteins | 1 | 2008 | 30 | 0.020 |
Why?
|
| Antigens | 1 | 2014 | 1441 | 0.020 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2008 | 29 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2020 | 3114 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2016 | 1273 | 0.020 |
Why?
|
| Autophagy | 1 | 2017 | 1327 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2012 | 904 | 0.020 |
Why?
|
| Vaccination | 1 | 2021 | 3369 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 4851 | 0.020 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2008 | 51 | 0.020 |
Why?
|
| Cortisone | 1 | 2008 | 87 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2007 | 3726 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2010 | 410 | 0.020 |
Why?
|
| Metabolome | 1 | 2015 | 989 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2010 | 267 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 14610 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2008 | 78 | 0.020 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 2007 | 58 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2009 | 265 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 2477 | 0.020 |
Why?
|
| Iron Chelating Agents | 1 | 2008 | 141 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 284 | 0.020 |
Why?
|
| Collagen | 1 | 2016 | 2635 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 1347 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2007 | 317 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2008 | 522 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2021 | 5521 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2012 | 1558 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2008 | 291 | 0.020 |
Why?
|
| Hydrogels | 1 | 2012 | 720 | 0.020 |
Why?
|
| Mast Cells | 1 | 2014 | 1392 | 0.020 |
Why?
|
| Mesoderm | 1 | 2010 | 673 | 0.020 |
Why?
|
| Staurosporine | 1 | 2007 | 241 | 0.020 |
Why?
|
| Aorta | 1 | 2014 | 2040 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2001 | 3534 | 0.020 |
Why?
|
| United States | 3 | 2021 | 72339 | 0.020 |
Why?
|
| Hydroxylation | 1 | 2006 | 137 | 0.020 |
Why?
|
| RNA Stability | 1 | 2008 | 317 | 0.020 |
Why?
|
| Multigene Family | 1 | 2010 | 1075 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 2227 | 0.020 |
Why?
|
| Health Personnel | 1 | 2020 | 3337 | 0.020 |
Why?
|
| Proteomics | 1 | 2020 | 3840 | 0.020 |
Why?
|
| Thrombopoietin | 1 | 2008 | 226 | 0.020 |
Why?
|
| Thrombocytosis | 1 | 2006 | 88 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2021 | 4642 | 0.020 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2006 | 105 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2010 | 720 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1662 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 1668 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1331 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2006 | 257 | 0.020 |
Why?
|
| Indoles | 1 | 2013 | 1830 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2013 | 1873 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1405 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2010 | 1084 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 6341 | 0.020 |
Why?
|
| Cycloheximide | 2 | 1996 | 343 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 1720 | 0.020 |
Why?
|
| Hydrogen Bonding | 2 | 1996 | 289 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 1995 | 2636 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 1216 | 0.010 |
Why?
|
| Cell Movement | 1 | 2016 | 5195 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2010 | 1144 | 0.010 |
Why?
|
| CHO Cells | 2 | 1998 | 1379 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9278 | 0.010 |
Why?
|
| Elasticity | 1 | 2006 | 655 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2013 | 2623 | 0.010 |
Why?
|
| Finite Element Analysis | 1 | 2006 | 437 | 0.010 |
Why?
|
| Memory | 1 | 2013 | 2190 | 0.010 |
Why?
|
| Internet | 1 | 2016 | 3096 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2024 | 11476 | 0.010 |
Why?
|
| Epidermis | 1 | 2006 | 526 | 0.010 |
Why?
|
| Cricetinae | 2 | 1998 | 2412 | 0.010 |
Why?
|
| Motor Activity | 1 | 2013 | 2712 | 0.010 |
Why?
|
| Horseradish Peroxidase | 1 | 1983 | 166 | 0.010 |
Why?
|
| Peroxidases | 1 | 1983 | 134 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3634 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1994 | 1053 | 0.010 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 1983 | 109 | 0.010 |
Why?
|
| Liver | 3 | 2007 | 7514 | 0.010 |
Why?
|
| Lung | 1 | 2021 | 9979 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2014 | 3813 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2005 | 432 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5333 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 3590 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2010 | 3155 | 0.010 |
Why?
|
| Aminolevulinic Acid | 1 | 2003 | 145 | 0.010 |
Why?
|
| Metaplasia | 1 | 2003 | 324 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2008 | 1607 | 0.010 |
Why?
|
| Circular Dichroism | 2 | 1998 | 334 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 4673 | 0.010 |
Why?
|
| Organ Size | 1 | 2006 | 2253 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2001 | 6919 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1983 | 413 | 0.010 |
Why?
|
| Obesity | 1 | 2023 | 12939 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2008 | 1818 | 0.010 |
Why?
|
| Liver Neoplasms | 4 | 2001 | 4309 | 0.010 |
Why?
|
| Length of Stay | 1 | 2014 | 6417 | 0.010 |
Why?
|
| Skin | 1 | 2014 | 4473 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4909 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8663 | 0.010 |
Why?
|
| Research Design | 1 | 2016 | 6180 | 0.010 |
Why?
|
| Mitosis | 1 | 2005 | 1186 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1983 | 731 | 0.010 |
Why?
|
| Synaptic Membranes | 1 | 1999 | 89 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2006 | 1231 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7400 | 0.010 |
Why?
|
| Receptors, GABA-B | 1 | 1999 | 58 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10218 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1999 | 366 | 0.010 |
Why?
|
| Anxiety | 1 | 2013 | 4569 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3245 | 0.010 |
Why?
|
| Photosensitizing Agents | 1 | 2003 | 625 | 0.010 |
Why?
|
| Photoaffinity Labels | 1 | 1998 | 85 | 0.010 |
Why?
|
| Potentiometry | 1 | 1997 | 10 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2008 | 2640 | 0.010 |
Why?
|
| Photochemistry | 1 | 1998 | 238 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2010 | 3671 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 1995 | 2293 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1999 | 1308 | 0.010 |
Why?
|
| Anticonvulsants | 2 | 1998 | 1910 | 0.010 |
Why?
|
| Hyperthermia, Induced | 1 | 2001 | 417 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 2691 | 0.010 |
Why?
|
| Endocytosis | 1 | 2001 | 950 | 0.010 |
Why?
|
| Ileum | 1 | 1999 | 557 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1980 | 674 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 1996 | 93 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2008 | 1920 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 4340 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2008 | 2278 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 2261 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 4618 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2003 | 1490 | 0.010 |
Why?
|
| DNA Probes | 1 | 1996 | 542 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1999 | 927 | 0.010 |
Why?
|
| RNA, Small Nuclear | 1 | 1995 | 71 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 1995 | 157 | 0.010 |
Why?
|
| TATA Box | 1 | 1994 | 127 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1999 | 1200 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1995 | 704 | 0.010 |
Why?
|
| Pregnancy Proteins | 1 | 1995 | 223 | 0.010 |
Why?
|
| Cyanides | 1 | 1994 | 82 | 0.010 |
Why?
|
| Intestines | 1 | 2003 | 1908 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1995 | 1083 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1995 | 748 | 0.010 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 1995 | 254 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 1994 | 221 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2006 | 5969 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1994 | 590 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2001 | 2913 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1995 | 617 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 1995 | 672 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2007 | 3163 | 0.010 |
Why?
|
| Lymphokines | 1 | 1995 | 925 | 0.010 |
Why?
|
| Electron Spin Resonance Spectroscopy | 2 | 1983 | 161 | 0.010 |
Why?
|
| Neurons | 1 | 1991 | 9428 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1997 | 1047 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1997 | 1075 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2007 | 4251 | 0.010 |
Why?
|
| Biopsy | 1 | 2003 | 6781 | 0.010 |
Why?
|
| Tritium | 1 | 1991 | 706 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1991 | 453 | 0.010 |
Why?
|
| Autoradiography | 1 | 1991 | 729 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2001 | 2827 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1991 | 2087 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2001 | 3461 | 0.010 |
Why?
|
| Drosophila | 1 | 1997 | 1495 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1994 | 4167 | 0.000 |
Why?
|
| Transforming Growth Factor beta | 1 | 1995 | 1963 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1996 | 3770 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 6504 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1994 | 3661 | 0.000 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1995 | 3493 | 0.000 |
Why?
|
| Aminopyrine | 1 | 1983 | 6 | 0.000 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1980 | 117 | 0.000 |
Why?
|
| Protein Denaturation | 1 | 1980 | 241 | 0.000 |
Why?
|
| Viscosity | 1 | 1980 | 335 | 0.000 |
Why?
|
| Disulfides | 1 | 1980 | 463 | 0.000 |
Why?
|
| Rabbits | 1 | 1983 | 4750 | 0.000 |
Why?
|
| Cysteine | 1 | 1980 | 888 | 0.000 |
Why?
|
| Temperature | 1 | 1980 | 2219 | 0.000 |
Why?
|